143 related articles for article (PubMed ID: 26632172)
1. Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease.
Yoshioka W; Miyauchi A; Ito M; Kudo T; Tamai H; Nishihara E; Kihara M; Miya A; Amino N
Endocr J; 2016; 63(2):179-85. PubMed ID: 26632172
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy.
Takamura Y; Nakano K; Uruno T; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Endocr J; 2003 Oct; 50(5):595-601. PubMed ID: 14614216
[TBL] [Abstract][Full Text] [Related]
3. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
4. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
[TBL] [Abstract][Full Text] [Related]
5. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
6. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
7. Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
Hamada N; Momotani N; Ishikawa N; Yoshimura Noh J; Okamoto Y; Konishi T; Ito K; Ito K
Endocr J; 2011; 58(1):55-8. PubMed ID: 20962435
[TBL] [Abstract][Full Text] [Related]
8. Neonatal hyperthyroidism: neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy.
Zuppa AA; Sindico P; Savarese I; D'Andrea V; Fracchiolla A; Cota F; Romagnoli C
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):535-9. PubMed ID: 17550218
[TBL] [Abstract][Full Text] [Related]
9. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
Suzuki N; Yoshihara A; Yoshimura Noh J; Kinoshita K; Ohnishi J; Saito M; Sugino K; Ito K
Endocr J; 2020 Oct; 67(10):1019-1022. PubMed ID: 32522908
[TBL] [Abstract][Full Text] [Related]
10. [Fetal and neonatal outcomes in infants of mothers with TSH receptor antibody positivity in pregnancy].
Zuppa AA; Perrone S; Sindico P; Alighieri G; Antichi E; Carducci C; Romagnoli C
Pediatr Med Chir; 2009; 31(2):72-7. PubMed ID: 19642499
[TBL] [Abstract][Full Text] [Related]
11. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
12. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of thyrotropin receptor antibodies using the second generation TRAb human assay after radioiodine treatment in Graves' disease].
Zöphel K; Wunderlich G; Kopprasch C; Koch R; Franke WG; Kotzerke J
Nuklearmedizin; 2003; 42(2):63-70. PubMed ID: 12695788
[TBL] [Abstract][Full Text] [Related]
14. TSH receptor antibody as a predictor of difficult robotic thyroidectomy in patients with Graves' disease.
Lee JK; Kong Y; Choi JB; Kim W; Yu HW; Kim SJ; Chai YJ; Choi JY; Lee KE
J Robot Surg; 2024 Mar; 18(1):108. PubMed ID: 38436742
[TBL] [Abstract][Full Text] [Related]
15. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
16. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
Smit MA; van Kinschot CMJ; van der Linden J; van Noord C; Kos S
Neth J Med; 2020 Mar; 78(2):55-63. PubMed ID: 32332174
[TBL] [Abstract][Full Text] [Related]
17. Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy.
Nart A; Uslu A; Aykas A; Yuzbasioglu F; Dogan M; Demirtas O; Simsek C
Asian J Surg; 2008 Jul; 31(3):115-8. PubMed ID: 18658008
[TBL] [Abstract][Full Text] [Related]
18. [Outcome of surgical treatment for Graves's disease and a correlation between its clinical course and values of TSH receptor antibodies (TRAb)].
Sugino K; Mimura T; Toshima K; Ozaki O; Ito K
Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):611-4. PubMed ID: 8341243
[TBL] [Abstract][Full Text] [Related]
19. Performance of a third-generation TSH-receptor antibody in a UK clinic.
Theodoraki A; Jones G; Parker J; Woolman E; Martin N; Perera S; Thomas M; Bunn C; Khoo B; Bouloux PM; Vanderpump MP
Clin Endocrinol (Oxf); 2011 Jul; 75(1):127-33. PubMed ID: 21521291
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
